COVID-19 Vaccine Janssen

COVID-19 Vaccine Janssen

Janssen Pharmaceutica (Pty) Ltd, as directed by the South African Health Products Regulatory Authority (SAHPRA) would like to inform you about new safety information that has resulted in contraindication of the COVID-19 Vaccine Janssen in individuals with a history of Capillary Leak Syndrome (CLS).

2021 Jul

Download latest version
File Type: pdf
Category: Communication To Health Care Professionals
Unit: pharmacovigilance